Vice President, CMC Development and Drug Delivery Innovation

You lead CMC and device development at the company, a late clinical-stage biotechnology company developing GLP-1-based therapies for obesity, including ribupatide (injectable, once-weekly, in global Phase 3 trials), an…

Full role details are a member benefit.